Posted on April 6, 2010 by Sitemaster
Most brachytherapy centers today use the Phoenix criteria to define clinical success and failure after brachytherapy. But a new paper suggests that brachytherapy can (and perhaps should) use a higher standard for long-term follow-up. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: brachytherapy, outcome, PSA level | 4 Comments »
Posted on January 28, 2010 by Sitemaster
The news reports today cover studies on:
- Initial PSA levels and risk for prostate cancer in black and in white Americans
- 3 T MR imaging, MRI-guided biopsies, and identification of sites of local recurrence after first-line EBRT
- pT0 disease in men with biopsy-detected prostate cancer
- Outcomes of immediate surgery compared to deferred treatment … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: defferred, immediate, MRI-guided biopsy, PSA level, pT0 disease, race, risk, surgery, Treatment | 7 Comments »
Posted on July 18, 2009 by Sitemaster
In today’s news reports you will find items on:
- Obesity and PSA levels
- Outcomes after external beam radiation therapy
- Mitoxantrone + predisone after taxotere failure … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: EBRT, external beam radiation therapy, mitoxantrone, obesity, outcome, prednisone, PSA level | Leave a comment »
Posted on April 13, 2009 by Sitemaster
Over the years there have been several studies suggesting that regular use of non-steroidal anti-inflammatory agents (NSAIDs) — the most common being aspirin — can decrease prostate inflammation and prostate cancer risk. Since aspirin and other NSAIDs are commonly used to prevent cardiovascular disease, it will be apparent that there is going to be relatively high use of these agents in the men who are also at some degree of risk for prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: aspirin, NSAID, Prevention, PSA level, volume | Leave a comment »